We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
-$502M
Cap. Flow
-$489M
Cap. Flow %
-4.05%
Top 10 Hldgs %
13.99%
Holding
580
New
160
Increased
90
Reduced
147
Closed
142

Top Sells

Rank Stock Value
1
AZO icon
AutoZone
AZO
+$193M
2
GE icon
GE Aerospace
GE
+$149M
3
AYI icon
Acuity Brands
AYI
+$143M
4
KEY icon
KeyCorp
KEY
+$133M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$131M

Sector Composition

Rank Sector Weight
1 Technology 20.78%
2 Industrials 13.32%
3 Healthcare 10.76%
4 Energy 9.69%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANTH
426
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$266K ﹤0.01%
830,674
+484,663
+140% +$724K
ACRE
427
Ares Commercial Real Estate
ACRE
$270M
$250K ﹤0.01%
+20,283
New +$255K
SLS icon
428
CALL
SELLAS Life Sciences
SLS
$2.36B
$244K ﹤0.01%
1,415
+1,368
+2,911% +$391K
VLRX
429
DELISTED
VALERITAS HOLDINGS INC
VLRX
$235K ﹤0.01%
4,354
-39
-0.9% -$2.45K
SU icon
430
Suncor Energy
SU
$70.3B
$223K ﹤0.01%
+6,448
New +$225K
TCON
431
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$223K ﹤0.01%
484
-4
-0.8% -$2.18K
VTVT icon
432
vTv Therapeutics
VTVT
$139M
$220K ﹤0.01%
1,349
-3,380
-71% -$827K
ATXS
433
DELISTED
Astria Therapeutics
ATXS
$213K ﹤0.01%
1,960
-1,685
-46% -$168K
NTBL
434
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$192K ﹤0.01%
2,381
ARGS
435
CALL
DELISTED
Argos Therapeutics, Inc.
ARGS
$180K ﹤0.01%
200,000
+190,000
+1,900% +$356K
GEVO icon
436
CALL
Gevo
GEVO
$382M
$45K ﹤0.01%
4,852
NVCN
437
DELISTED
Neovasc Inc.
NVCN
$7K ﹤0.01%
4
ADSK icon
438
Autodesk
ADSK
$52.6B
-165,032
Closed -$17.3M
ALL icon
439
Allstate
ALL
$67.5B
-230,955
Closed -$24.2M
AR icon
440
Antero Resources
AR
$10.7B
-889,581
Closed -$16.9M
ARGX icon
441
argenx
ARGX
$54.1B
-30,100
Closed -$1.9M
ASUR icon
442
Asure Software
ASUR
$250M
-315,311
Closed -$4.45M
ATRA icon
443
Atara Biotherapeutics
ATRA
$76.1M
-6,995
Closed -$3.17M
AXP icon
444
American Express
AXP
$230B
-865,490
Closed -$86M
AZN icon
445
AstraZeneca
AZN
$250B
-1,178,615
Closed -$81.8M
AZUL
446
DELISTED
Azul
AZUL
-100,000
Closed -$2.38M
BAND
447
Bandwidth Inc
BAND
$1.61B
-300,000
Closed -$6.94M
BBWI icon
448
Bath & Body Works
BBWI
$4.1B
-1,323,893
Closed -$64.5M
BBY icon
449
Best Buy
BBY
$17.3B
-485,763
Closed -$33.3M
BCRX icon
450
BioCryst Pharmaceuticals
BCRX
$2.4B
-450,000
Closed -$2.21M

Similar funds

Alyeska Investment Group's Q1 2018 Portfolio in Review

As of Q1 2018, Alyeska Investment Group held 580 positions worth $12.1B, down 4% from $12.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group withdrew a net $489M in Q1 2018, closing 142 positions and reducing 147 holdings. Its most notable exit was GE Aerospace, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Philip Morris worth $145M.

  • Alyeska Investment Group's largest Q1 2018 buy was Philip Morris: 1,458,712 shares worth $145M.
  • Alyeska Investment Group added most to Check Point Software Technologies in Q1 2018, an estimated $181M increase.
  • Alyeska Investment Group's biggest Q1 2018 reduction was AutoZone, cutting an estimated $193M.
  • Alyeska Investment Group fully exited GE Aerospace in Q1 2018, selling an estimated $149M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $12.1B portfolio in Q1 2018.
  • Alyeska Investment Group opened 160 new positions and closed 142 in Q1 2018.
  • Alyeska Investment Group's portfolio value fell 4% quarter-over-quarter to $12.1B.

Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.